Stay updated on Dupilumab in Prurigo Nodularis: Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.

Latest updates to the Dupilumab in Prurigo Nodularis: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page. No study content is affected.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedRevision updated to v3.4.2 replacing v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check39 days agoChange DetectedAdded a 2026 Am J Clin Dermatol publication entry for dupilumab in prurigo nodularis and updated it to Revision: v3.4.1; removed the previous Online ahead of print entry for the same article (Revision: v3.4.0).SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now displays a Last Update Posted timestamp, and the label 'Last Update Posted (Estimated)' has been removed to clarify update timing. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.3.4 was released (replacing v3.3.3). There are no substantive changes to the study details or layout.SummaryDifference0.0%

- Check82 days agoChange DetectedThe Study Locations section was expanded to include numerous investigational sites in the US and internationally (Argentina, China, France, Japan, Mexico, Russia, South Korea, and more). This broadens recruitment geography.SummaryDifference2%

Stay in the know with updates to Dupilumab in Prurigo Nodularis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Prurigo Nodularis: Clinical Trial page.